Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation

Andrew L. Raines, Moonhae Sunwoo, Arthur A. Gertzman, Kipling Thacker, Robert E. Guldberg, Zvi Schwartz, Barbara D. Boyan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Restoration of vasculature is a critical component for successful integration of implants in musculoskeletal tissue. Sodium hyaluronate (NaHY) has been used as a carrier for demineralized bone matrix (DBM). DBM is osteoinductive and osteoconductive, but whether NaHY by itself has an effect is not known. NaHY has been reported to promote neovascularization, suggesting it may increase neovasculature when used with DBM as well. To test this, we used a rat tibial marrow ablation model to assess neovascularization during bone formation and regeneration of marrow with different combinations of NaHY alone and NaHY+DBM. To assess neovascularization during normal healing, animals were euthanized at 3-, 6-, 14-, 21-, and 28-days post-ablation, and the vasculature perfused using a radio-opaque contrast agent. Vascular morphology was assessed using μCT and histology. Peak vessel volume within the marrow cavity was observed on day-14 post-ablation. Test materials were injected into the ablated marrow space as follows: (A) empty defect controls; (B) high MW (700-800 kDa) NaHY + heat inactivated DBM; (C) DBM in PBS; (D) low MW NaHY (35 kDa) + DBM; (E) high MW NaHY + DBM; (F) D:E 50:50; (G) low MW NaHY; (H) high MW NaHY; and (I) G:H 50:50. Neovascularization varied with bone substitute formulation. μCT results revealed that addition of NaHY resulted in an increase in vessel number compared to empty defects. Total blood vessel volume in all NaHY only groups were similar to DBM alone. Histomorphometry of sagittal sections showed that all three formulations of NaHY increased blood vessel number within the marrow cavity, confirming that NaHY promotes neovascularization.

Original languageEnglish (US)
Pages (from-to)575-583
Number of pages9
JournalJournal of Biomedical Materials Research - Part A
Volume96 A
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Hyaluronic acid
Bone Matrix
Hyaluronic Acid
Ablation
Regeneration
Bone
Bone Marrow
Blood Vessels
Blood vessels
Bone Substitutes
Bone Regeneration
Defects
Histology
Blood Volume
Osteogenesis
Contrast Media
Restoration
Rats
Hot Temperature
Animals

Keywords

  • DBM plus hyaluronic acid
  • histomorphometry
  • microCT using a contrast agent to label vasculature
  • rat tibial bone marrow ablation
  • vasculogenesis

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys

Cite this

Raines, A. L., Sunwoo, M., Gertzman, A. A., Thacker, K., Guldberg, R. E., Schwartz, Z., & Boyan, B. D. (2011). Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation. Journal of Biomedical Materials Research - Part A, 96 A(3), 575-583. https://doi.org/10.1002/jbm.a.33012

Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation. / Raines, Andrew L.; Sunwoo, Moonhae; Gertzman, Arthur A.; Thacker, Kipling; Guldberg, Robert E.; Schwartz, Zvi; Boyan, Barbara D.

In: Journal of Biomedical Materials Research - Part A, Vol. 96 A, No. 3, 01.03.2011, p. 575-583.

Research output: Contribution to journalArticle

Raines, AL, Sunwoo, M, Gertzman, AA, Thacker, K, Guldberg, RE, Schwartz, Z & Boyan, BD 2011, 'Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation', Journal of Biomedical Materials Research - Part A, vol. 96 A, no. 3, pp. 575-583. https://doi.org/10.1002/jbm.a.33012
Raines, Andrew L. ; Sunwoo, Moonhae ; Gertzman, Arthur A. ; Thacker, Kipling ; Guldberg, Robert E. ; Schwartz, Zvi ; Boyan, Barbara D. / Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation. In: Journal of Biomedical Materials Research - Part A. 2011 ; Vol. 96 A, No. 3. pp. 575-583.
@article{70a280aae3a345d7803d0b193bb6c000,
title = "Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation",
abstract = "Restoration of vasculature is a critical component for successful integration of implants in musculoskeletal tissue. Sodium hyaluronate (NaHY) has been used as a carrier for demineralized bone matrix (DBM). DBM is osteoinductive and osteoconductive, but whether NaHY by itself has an effect is not known. NaHY has been reported to promote neovascularization, suggesting it may increase neovasculature when used with DBM as well. To test this, we used a rat tibial marrow ablation model to assess neovascularization during bone formation and regeneration of marrow with different combinations of NaHY alone and NaHY+DBM. To assess neovascularization during normal healing, animals were euthanized at 3-, 6-, 14-, 21-, and 28-days post-ablation, and the vasculature perfused using a radio-opaque contrast agent. Vascular morphology was assessed using μCT and histology. Peak vessel volume within the marrow cavity was observed on day-14 post-ablation. Test materials were injected into the ablated marrow space as follows: (A) empty defect controls; (B) high MW (700-800 kDa) NaHY + heat inactivated DBM; (C) DBM in PBS; (D) low MW NaHY (35 kDa) + DBM; (E) high MW NaHY + DBM; (F) D:E 50:50; (G) low MW NaHY; (H) high MW NaHY; and (I) G:H 50:50. Neovascularization varied with bone substitute formulation. μCT results revealed that addition of NaHY resulted in an increase in vessel number compared to empty defects. Total blood vessel volume in all NaHY only groups were similar to DBM alone. Histomorphometry of sagittal sections showed that all three formulations of NaHY increased blood vessel number within the marrow cavity, confirming that NaHY promotes neovascularization.",
keywords = "DBM plus hyaluronic acid, histomorphometry, microCT using a contrast agent to label vasculature, rat tibial bone marrow ablation, vasculogenesis",
author = "Raines, {Andrew L.} and Moonhae Sunwoo and Gertzman, {Arthur A.} and Kipling Thacker and Guldberg, {Robert E.} and Zvi Schwartz and Boyan, {Barbara D.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1002/jbm.a.33012",
language = "English (US)",
volume = "96 A",
pages = "575--583",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "3",

}

TY - JOUR

T1 - Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation

AU - Raines, Andrew L.

AU - Sunwoo, Moonhae

AU - Gertzman, Arthur A.

AU - Thacker, Kipling

AU - Guldberg, Robert E.

AU - Schwartz, Zvi

AU - Boyan, Barbara D.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Restoration of vasculature is a critical component for successful integration of implants in musculoskeletal tissue. Sodium hyaluronate (NaHY) has been used as a carrier for demineralized bone matrix (DBM). DBM is osteoinductive and osteoconductive, but whether NaHY by itself has an effect is not known. NaHY has been reported to promote neovascularization, suggesting it may increase neovasculature when used with DBM as well. To test this, we used a rat tibial marrow ablation model to assess neovascularization during bone formation and regeneration of marrow with different combinations of NaHY alone and NaHY+DBM. To assess neovascularization during normal healing, animals were euthanized at 3-, 6-, 14-, 21-, and 28-days post-ablation, and the vasculature perfused using a radio-opaque contrast agent. Vascular morphology was assessed using μCT and histology. Peak vessel volume within the marrow cavity was observed on day-14 post-ablation. Test materials were injected into the ablated marrow space as follows: (A) empty defect controls; (B) high MW (700-800 kDa) NaHY + heat inactivated DBM; (C) DBM in PBS; (D) low MW NaHY (35 kDa) + DBM; (E) high MW NaHY + DBM; (F) D:E 50:50; (G) low MW NaHY; (H) high MW NaHY; and (I) G:H 50:50. Neovascularization varied with bone substitute formulation. μCT results revealed that addition of NaHY resulted in an increase in vessel number compared to empty defects. Total blood vessel volume in all NaHY only groups were similar to DBM alone. Histomorphometry of sagittal sections showed that all three formulations of NaHY increased blood vessel number within the marrow cavity, confirming that NaHY promotes neovascularization.

AB - Restoration of vasculature is a critical component for successful integration of implants in musculoskeletal tissue. Sodium hyaluronate (NaHY) has been used as a carrier for demineralized bone matrix (DBM). DBM is osteoinductive and osteoconductive, but whether NaHY by itself has an effect is not known. NaHY has been reported to promote neovascularization, suggesting it may increase neovasculature when used with DBM as well. To test this, we used a rat tibial marrow ablation model to assess neovascularization during bone formation and regeneration of marrow with different combinations of NaHY alone and NaHY+DBM. To assess neovascularization during normal healing, animals were euthanized at 3-, 6-, 14-, 21-, and 28-days post-ablation, and the vasculature perfused using a radio-opaque contrast agent. Vascular morphology was assessed using μCT and histology. Peak vessel volume within the marrow cavity was observed on day-14 post-ablation. Test materials were injected into the ablated marrow space as follows: (A) empty defect controls; (B) high MW (700-800 kDa) NaHY + heat inactivated DBM; (C) DBM in PBS; (D) low MW NaHY (35 kDa) + DBM; (E) high MW NaHY + DBM; (F) D:E 50:50; (G) low MW NaHY; (H) high MW NaHY; and (I) G:H 50:50. Neovascularization varied with bone substitute formulation. μCT results revealed that addition of NaHY resulted in an increase in vessel number compared to empty defects. Total blood vessel volume in all NaHY only groups were similar to DBM alone. Histomorphometry of sagittal sections showed that all three formulations of NaHY increased blood vessel number within the marrow cavity, confirming that NaHY promotes neovascularization.

KW - DBM plus hyaluronic acid

KW - histomorphometry

KW - microCT using a contrast agent to label vasculature

KW - rat tibial bone marrow ablation

KW - vasculogenesis

UR - http://www.scopus.com/inward/record.url?scp=79251471436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251471436&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.33012

DO - 10.1002/jbm.a.33012

M3 - Article

C2 - 21254389

AN - SCOPUS:79251471436

VL - 96 A

SP - 575

EP - 583

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 0021-9304

IS - 3

ER -